发明授权
US08703946B2 Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors
有权
取代的吡唑并[1,5-A]吡嗪化合物作为mGluR5受体的变构调节剂
- 专利标题: Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors
- 专利标题(中): 取代的吡唑并[1,5-A]吡嗪化合物作为mGluR5受体的变构调节剂
-
申请号: US13314117申请日: 2011-12-07
-
公开(公告)号: US08703946B2公开(公告)日: 2014-04-22
- 发明人: P. Jeffrey Conn , Craig W. Lindsley , Carrie K. Jones , Shaun R. Stauffer , José Manuel Bartolome-Nebreda , Gregor James McDonald , Susana Conde-Ceide , Han Min Tong
- 申请人: P. Jeffrey Conn , Craig W. Lindsley , Carrie K. Jones , Shaun R. Stauffer , José Manuel Bartolome-Nebreda , Gregor James McDonald , Susana Conde-Ceide , Han Min Tong
- 申请人地址: US TN Nashville
- 专利权人: Vanderbilt University
- 当前专利权人: Vanderbilt University
- 当前专利权人地址: US TN Nashville
- 代理机构: Ballard Spahr LLP
- 主分类号: C07D471/00
- IPC分类号: C07D471/00
摘要:
In one aspect, the invention relates to substituted pyrazolo[1,5-a]pyrazine compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
公开/授权文献
信息查询